Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases

Brain Research

Volumn 1628, Issue , 2015, Pages 273-287

  Karuppagounder, Saravanan S ^a,b   Kumar, Amit ^a,b   Shao, Diana S ^a,b   Zille, Marietta ^a,b   Bourassa, Megan W ^a,b   Caulfield, Joseph T ^a,b   Alim, Ishraq ^a,b   Ratan, Rajiv R ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

Author keywords

2 Oxoglutarate dependent dioxygenases; Brain; Epigenetics; Metabolism; Neuroprotection; Stroke

Indexed keywords

2 OXOGLUTARIC ACID; HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE; IRON; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TRANSCRIPTION FACTOR; DIOXYGENASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN METABOLISM; CEREBROVASCULAR ACCIDENT; EPIGENETICS; FRIEDREICH ATAXIA; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; HYPOXIA; IRON DEFICIENCY; IRON METABOLISM; NERVE CELL NECROSIS; NERVOUS SYSTEM; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; SPINAL CORD INJURY; SPINAL MUSCULAR ATROPHY; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; TRAUMATIC BRAIN INJURY; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEUROLOGIC DISEASE;

ANIMALS; DIOXYGENASES; EPIGENESIS, GENETIC; HUMANS; IRON; NERVOUS SYSTEM DISEASES; OXYGEN;

EID: 84952638926     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.07.030     Document Type: Article

References (115)

1. M. Abematsu, and et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury J Clin Invest. 120 2010 3255 3266
2. H. Aleyasin, and et al. Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin Antioxid. Redox Signal. 22 2015 121 134
3. L.R. Aminova, and et al. Prosurvival and prodeath effects of hypoxia-inducible factor-1alpha stabilization in a murine hippocampal cell line J. Biol. Chem. 280 2005 3996 4003
4. L.R. Aminova, A. Siddiq, and R.R. Ratan Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line Antioxid. Redox Signal. 10 2008 1989 1998
5. A.M. Avila, and et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy J Clin Invest. 117 2007 659 671
6. U. Berchner-Pfannschmidt, and et al. Nuclear oxygen sensing: induction of endogenous prolyl-hydroxylase 2 activity by hypoxia and nitric oxide J. Biol. Chem. 283 2008 31745 31753
7. M. Bergeron, and et al. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain Ann. Neurol. 48 2000 285 296
8. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4-hydroxylases that modify HIF Science 294 2001 1337 1340
9. L. Cai, and et al. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes Molecular Cell 42 2011 426 437
10. S. Camelo, and et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis J Neuroimmunol. 164 2005 10 21
11. G. Castelo-Branco, and et al. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats Neurobiol Dis. 71 2014 220 233
12. A.A. Castro, and et al. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease Behav Brain Res. 229 2012 208 215
13. J.G. Chang, and et al. Treatment of spinal muscular atrophy by sodium butyrate Proc Natl Acad Sci U S A 98 2001 9808 9813
14. X. Chang, and et al. (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimers disease model mice by upregulating neprilysin expression Exp Cell Res. 334 2015 136 145
15. C.H. Cherng, and et al. Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats J Formos Med Assoc. 113 2014 513 520
16. C.T. Chiu, and et al. Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease Neuropsychopharmacology 36 2011 2406 2421
17. A.H. Chou, and et al. HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3 Neurobiol Dis. 41 2011 481 488
18. S. Dasgupta, and et al. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps J Immunol. 170 2003 3874 3882
19. P.K. Dash, S.A. Orsi, and A.N. Moore Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury Neuroscience 163 2009 1 8
20. P.K. Dash, and et al. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats PLoS One 5 2010 e11383
21. S.J. Del Signore, and et al. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice Amyotroph Lateral Scler. 10 2009 85 94
22. F. Denk, and et al. HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain Pain 154 2013 1668 1679
23. H.K. Eltzschig, D.L. Bratton, and S.P. Colgan Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases Nat. Rev. Drug Discov. 13 2014 852 869
24. G. Faraco, and et al. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain Mol Pharmacol. 70 2006 1876 1884
25. H.L. Feng, and et al. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model Neuroscience 155 2008 567 572
26. R.J. Ferrante, and et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J Neurosci. 23 2003 9418 9427
27. B. Fleiss, and et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury J Neuroinflammation 9 2012 70
28. G. Gardian, and et al. Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity Neuromolecular Med. 5 2004 235 241
29. G. Gardian, and et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease J Biol Chem. 280 2005 556 563
30. Z. Ge, and et al. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis Exp Neurol. 241 2013 56 66
31. J.U. Guo, and et al. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond Cell Cycle 10 2011 2662 2668
32. M.A. Hahn, and et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis Cell Rep. 3 2013 291 300
33. R.L. Hancock, and et al. Epigenetic regulation by histone demethylases in hypoxia Epigenomics 2015 1 21
34. H.H. Hao, and et al. Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats Neurosci Bull 29 2013 484 492
35. A. Hausmann, and et al. Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis J. Biol. Chem. 283 2008 8318 8330
36. P.W. Hill, R. Amouroux, and P. Hajkova DNA demethylation, Tet proteins and 5-hydroxymethylcytosine in epigenetic reprogramming: an emerging complex story Genomics 104 2014 324 333
37. E. Hockly, and et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc Natl Acad Sci U S A 100 2003 2041 2046
38. M. Inden, and et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone J Neurochem. 101 2007 1491 1504
39. J.S. Isaacs, and et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 8 2005 143 153
40. A.R. Isles Neural and behavioral epigenetics; what it is, and what is hype Genes Brain Behav. 14 2015 64 72
41. H. Jia, and et al. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems Hum Mol Genet. 21 2012 5280 5293
42. W.G. Kaelin, Jr., and P.J. Ratcliffe Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway Mol. Cell 30 2008 393 402
43. S.S. Karuppagounder, and R.R. Ratan Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J. Cereb. Blood Flow Metab. 32 2012 1347 1361
44. S.S. Karuppagounder, and et al. In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1alpha by inhibition of synthesis and not enhanced degradation J. Neurosci. Res. 91 2013 1066 1075
45. S.K. Kidd, and J.S. Schneider Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Neuroscience 194 2011 189 194
46. H.J. Kim, and et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action J Pharmacol Exp Ther. 321 2007 892 901
47. H.J. Kim, P. Leeds, and D.M. Chuang The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain J Neurochem. 110 2009 1226 1240
48. C. Klein, and et al. gamma-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease Neurobiol Aging. 36 2015 832 844
49. M. Ko, and et al. TET proteins and 5-methylcytosine oxidation in hematological cancers Immunol. Rev. 263 2015 6 21
50. C. Kuiper, and M.C. Vissers Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression Front. Oncol. 4 2014 359
51. A. Kukkar, N. Singh, and A.S. Jaggi Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats J Formos Med Assoc. 113 2014 921 928
52. B. Langley, and et al. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21waf1/cip1 in cell cycle-independent neuroprotection J. Neurosci. 28 2008 163 176
53. B. Langley, and et al. Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection J Neurosci. 28 2008 163 176
54. H.Y. Lee, and et al. HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions Mol. Cells 37 2014 43 50
55. J.Y. Lee, and et al. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury J Neurochem. 121 2012 818 829
56. T. Li, and et al. Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation Mol. Neurobiol. 51 2015 142 154
57. X.S. Liu, and et al. Valproic acid increases white matter repair and neurogenesis after stroke Neuroscience 220 2012 313 321
58. C. Loenarz, and C.J. Schofield Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases Trends Biochem. Sci. 36 2011 7 18
59. W.H. Lu, and et al. Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia J Neurosci Res. 91 2013 694 705
60. L. Lv, and et al. Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro Exp Neurol. 233 2012 783 790
61. N. Maio, and T.A. Rouault Iron-sulfur cluster biogenesis in mammalian cells: new insights into the molecular mechanisms of cluster delivery Biochim. Biophys. Acta 1853 2015 1493 1512
62. Y. Matsushita, and et al. HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model Br J Pharmacol. 170 2013 991 998
63. M. Mellen, and et al. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system Cell 151 2012 1417 1430
64. M. Minamiyama Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Hum Mol Genet. 13 2004 1183 1192
65. B. Monti, and et al. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein Neurotox Res. 17 2010 130 141
66. B. Monti, D. Mercatelli, and A. Contestabile Valproic acid neuroprotection in 6-OHDA lesioned rat, a model for parkinson's disease HOAJ Biology 2012 1
67. A. Nandal, and et al. Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2 Cell Metab. 14 2011 647 657
68. H.L. Narver, and et al. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition Ann Neurol. 64 2008 465 470
69. Z. Niatsetskaya, and et al. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease Antioxid. Redox Signal. 12 2010 435 443
70. H. Noh, and H. Seo Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation Neuroscience 266 2014 255 265
71. D.E. Olson, and et al. Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism Chem. Biol. 22 2015 439 445
72. K. Ono, and et al. A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice Parkinsonism Relat Disord. 15 2009 649 654
73. A. Ozer, and R.K. Bruick Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat. Chem. Biol. 3 2007 144 153
74. W.A. Pastor, L. Aravind, and A. Rao TETonic shift: biological roles of TET proteins in DNA demethylation and transcription Nat. Rev. Mol. Cell Biol. 14 2013 341 356
75. Z.J. Reitman, and H. Yan Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism J. Natl. Cancer Inst. 102 2010 932 941
76. M. Ren, and et al. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction J Neurochem. 89 2004 1358 1367
77. M. Riessland, and et al. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy Hum Mol Genet. 19 2010 1492 1506
78. S.M. Ronnebaum, and et al. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion J. Biol. Chem. 281 2006 30593 30602
79. A. Roy, and et al. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease PLoS One 7 2012 e38113
80. K. Ruscher, and et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model J. Neurosci. 22 2002 10291 10301
81. H. Ryu, and et al. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway Proc. Natl. Acad. Sci. 100 2003 4281 4286
82. H. Ryu, and et al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice J. Neurochem. 93 2005 1087 1098
83. C. Sandi, and et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model Neurobiol Dis. 42 2011 496 505
84. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol. Cell. Biol. 12 1992 5447 5454
85. G.L. Semenza Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology Annu. Rev. Pathol. 9 2014 47 71
86. N.A. Shein, and et al. Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury FASEB J 23 2009 4266 4275
87. A. Shmakova, and et al. Chromatin and oxygen sensing in the context of JmjC histone demethylases Biochem. J. 462 2014 385 395
88. A. Siddiq, and et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system J. Biol. Chem. 280 2005 41732 41743
89. A. Siddiq, and et al. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways J. Neurosci. 29 2009 8828 8838
90. D.I. Sinn, and et al. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation Neurobiol Dis. 26 2007 464 472
91. S. Sleiman, and et al. Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition J. Neurosci. 2014
92. S.M. Smith, R.S. Kimyon, and J.J. Watters Cell-type-specific Jumonji histone demethylase gene expression in the healthy rat CNS: detection by a novel flow cytometry method ASN Neuro. 6 2014 193 207
93. R.E. Speer, and et al. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke Free Radic. Biol. Med. 62 2013 26 36
94. J.S. Steffan, and et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743
95. F. Sugai, and et al. Benefit of valproic acid in suppressing disease progression of ALS model mice Eur J Neurosci. 20 2004 3179 3183
96. H. Takahashi, and et al. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription Molecular Cell. 23 2006 207 217
97. L. Tan, and Y.G. Shi Tet family proteins and 5-hydroxymethylcytosine in development and disease Development 139 2012 1895 1902
98. K. Thirstrup, and et al. Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors Pharmacol. Res. 64 2011 268 273
99. E.A. Thomas, and et al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice Proc Natl Acad Sci U S A 105 2008 15564 15569
100. L.K. Tsai, and et al. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy Neurobiol Dis. 24 2006 286 295
101. G. Vangeison, and et al. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes J. Neurosci. 28 2008 1988 1993
102. B. Wang, and et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage Free Radic Biol Med. 52 2012 928 936
103. K.E. Wellen, and et al. ATP-citrate lyase links cellular metabolism to histone acetylation Science 324 2009 1076 1080
104. J.C. Wiley, C. Pettan-Brewer, and W.C. Ladiges Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice Aging Cell. 10 2011 418 428
105. C.C. Winterbourn, and A.J. Kettle Redox reactions and microbial killing in the neutrophil phagosome Antioxid. Redox Signal. 18 2013 642 660
106. A. Xuan, and et al. Neuroprotective effects of valproic acid following transient global ischemia in rats Life Sci. 90 2012 463 468
107. F. Yildirim, and et al. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury Exp Neurol. 210 2008 531 542
108. M. Ying, and et al. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA J Biol Chem. 281 2006 12580 12586
109. Y.E. Yoo, and C.P. Ko Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis Exp Neurol. 231 2011 147 159
110. F. Yu, and et al. Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury J Neurosurg. 119 2013 766 773
111. H. Yu, and et al. Tet3 regulates synaptic transmission and homeostatic plasticity via DNA oxidation and repair Nat. Neurosci. 18 2015 836 843
112. S.H. Yu, and et al. The neuroprotective effect of treatment of valproic Acid in acute spinal cord injury J Korean Neurosurg Soc. 51 2012 191 198
113. D. Zadori, and et al. Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease Pharmacol Biochem Behav. 94 2009 148 153
114. K. Zaman, and et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin J. Neurosci. 19 1999 9821 9830
115. W. Zhou, and et al. Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease J Biol Chem. 286 2011 14941 14951